Get the Stockscreener App
4.06
6.88%
-0.30
After Hours:
4.01
-0.05
-1.23%
Sana Biotechnology Inc stock is traded at $4.06, with a volume of 3.55M.
It is down -6.88% in the last 24 hours and up +48.72% over the past month.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
See More
Previous Close:
$4.36
Open:
$4.295
24h Volume:
3.55M
Relative Volume:
0.76
Market Cap:
$915.44M
Revenue:
-
Net Income/Loss:
$-283.26M
P/E Ratio:
-2.7619
EPS:
-1.47
Net Cash Flow:
$-273.61M
1W Performance:
-20.86%
1M Performance:
+48.72%
6M Performance:
+26.09%
1Y Performance:
-33.33%
1-Day Range:
$4.04
$4.30
1-Week Range:
$4.04
$5.20
52-Week Range:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
(206) 701-7914
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Compare SANA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
4.06 | 983.42M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Mar-18-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Mar-14-25 | Initiated | Jefferies | Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Nov-05-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Rodman & Renshaw | Buy |
| Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Aug-14-23 | Initiated | TD Cowen | Market Perform |
| May-02-23 | Initiated | H.C. Wainwright | Neutral |
| Mar-01-21 | Initiated | BofA Securities | Buy |
| Mar-01-21 | Initiated | Goldman | Neutral |
| Mar-01-21 | Initiated | JP Morgan | Neutral |
| Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
Citi Remains Bullish on Sana Biotechnology (SANA) - Insider Monkey
What is Sana Biotechnology Inc. company’s growth strategyWealth Building Planner With Proven Results - jammulinksnews.com
Is Sana Biotechnology Inc. a growth stock or a value stockFree Stock Recommendation For Fast Growth - jammulinksnews.com
When is Sana Biotechnology Inc. stock expected to show significant growthEarnings Report Insights To Watch Now - jammulinksnews.com
10 Penny Stocks That Will Skyrocket - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
Why Sana Biotechnology Inc. stock attracts strong analyst attentionEntry Plan for Oversold Reversal Stocks Released - beatles.ru
Published on: 2025-07-29 13:54:31 - metal.it
Trading Bots Trigger Alerts on Sana Biotechnology Inc. ActivityTrade Insight With Community Collaboration Supported - metal.it
How volatile is Sana Biotechnology Inc. stock compared to the marketDaily Trading Entry Points For Every Investor - jammulinksnews.com
Is it the right time to buy Sana Biotechnology Inc. stockFinancial News Alerts With Proven Results - jammulinksnews.com
Is Sana Biotechnology Inc. stock overvalued or undervaluedGet exclusive market insights for better trading - jammulinksnews.com
Should I hold or sell Sana Biotechnology Inc. stock in 2025Track top-performing stocks effortlessly - jammulinksnews.com
How does Sana Biotechnology Inc. compare to its industry peersCapitalize on fast-moving trading opportunities - jammulinksnews.com
What catalysts could drive Sana Biotechnology Inc. stock higher in 2025Accelerated financial growth - jammulinksnews.com
How Sana Biotechnology Inc. stock performs during market volatilityFree Membership Group - metal.it
Is Sana Biotechnology Inc. a good long term investmentSuperior capital gains - PrintWeekIndia
What drives Sana Biotechnology Inc. stock priceConsistently profitable trades - Autocar Professional
When is the best time to buy Sana Biotechnology Inc. stockFree Stock Market Forecast Reports - jammulinksnews.com
What analysts say about Sana Biotechnology Inc. stockExceptional risk-adjusted gains - Autocar Professional
Citi Maintained a Buy Rating on Sana Biotechnology (SANA) - MSN
Sana Biotechnology Inc. Stock Analysis and ForecastHigh-velocity capital appreciation - jammulinksnews.com
11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey
Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results - MSN
Commit To Purchase Sana Biotechnology At $2.50, Earn 28% Using Options - Nasdaq
Sana Biotechnology Inc Stock (SANA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):